How do Swiss general practitioners agree with and report adhering to a top-five list of unnecessary tests and treatments? Results of a cross-sectional survey. by Selby, K. et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=igen20
Download by: [Universitaire De Lausanne] Date: 13 January 2018, At: 02:33
European Journal of General Practice
ISSN: 1381-4788 (Print) 1751-1402 (Online) Journal homepage: http://www.tandfonline.com/loi/igen20
How do Swiss general practitioners agree with and
report adhering to a top-five list of unnecessary
tests and treatments? Results of a cross-sectional
survey
Kevin Selby, Jacques Cornuz, Christine Cohidon, Jean-Michel Gaspoz &
Nicolas Senn
To cite this article: Kevin Selby, Jacques Cornuz, Christine Cohidon, Jean-Michel Gaspoz &
Nicolas Senn (2017): How do Swiss general practitioners agree with and report adhering to a
top-five list of unnecessary tests and treatments? Results of a cross-sectional survey, European
Journal of General Practice, DOI: 10.1080/13814788.2017.1395018
To link to this article:  https://doi.org/10.1080/13814788.2017.1395018
© 2017 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
Published online: 23 Nov 2017.
Submit your article to this journal 
Article views: 169
View related articles 
View Crossmark data
ORIGINAL ARTICLE
How do Swiss general practitioners agree with and report adhering to a
top-five list of unnecessary tests and treatments? Results of a cross-sectional
survey
Kevin Selbya,b, Jacques Cornuza, Christine Cohidona,c, Jean-Michel Gaspozd and Nicolas Senna,c
aDepartment of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland; bDivision of Research,
Kaiser Permanente Northern California, Oakland, CA, USA; cInstitute of Family Medicine, University of Lausanne, Lausanne,
Switzerland; dDivision of Primary Care Medicine, Department of Community Medicine, Primary Care and Emergency Medicine, Geneva
University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland
KEY MESSAGES
 The ‘Smarter Medicine’ campaign adopted a top five list of unnecessary tests and treatments for Swiss pri-
mary care.
 General practitioners agree with all of the recommendations but report low adherence to the recommenda-
tion to down-titrate or stop chronic prescriptions of proton pump inhibitors.
ABSTRACT
Background: In 2014, the ‘Smarter Medicine’ campaign released a top five list of unnecessary
tests and treatments in Swiss primary care, such as imaging for acute low-back pain and long-
term prescribing of proton pump inhibitors.
Objectives: Measure general practitioners’ (GPs) agreement with the recommendations and self-
reported adherence.
Methods: Cross-sectional, online survey of GPs in the ‘Swiss primary care active monitoring’
(SPAM) network, which assessed awareness of ‘Smarter Medicine’ and views on each recommen-
dation. Questions included whether the clinical situation is common, whether the recommenda-
tion is followed, whether GPs agree with the recommendation and reasons why the
recommendation would not be followed.
Results: One-hundred-and-sixty-seven of 277 GPs from the SPAM network participated (60%), of
which 104 (62%) knew of ‘Smarter Medicine’, including 79% in German areas, 49% in French
areas and 38% in Italian areas (P< 0.001). Agreement with the five recommendations was high,
with scores around nine out of 10. The proportion saying they typically follow each recommen-
dation was 68 to 74%, except not continuing long-term PPI prescriptions without attempting
dose reduction, with only 34%. Common reasons for not following the recommendations were
patient or other provider requests and situations that might suggest the need for more aggres-
sive care.
Conclusion: Two years after the launch of the campaign, awareness and acceptance of ‘Smarter
Medicine’ appear to be high among Swiss GPs. By self-report, the recommendations are adhered
to by most of the respondents but there may be room for improvement, especially for long-
term PPI prescriptions.
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Introduction
There has been an international drive by physician
societies to identify unnecessary tests and treatments.
Under the banner of the ‘Choosing Wisely’ campaign,
initiatives have appeared in multiple countries, includ-
ing the United States, Canada, Netherlands, UK,
Australia and Germany [1,2]. The campaigns encourage
‘evidence-based conversations about what tests and
treatments may not benefit [patients] and could cause
harm [1].’
While the Swiss healthcare system does well on glo-
bal indicators of quality, it has the second-highest
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per-capita expenditures in the world. With a fee-for-
service payment structure and very high out-of-
pocket costs, there is increasing public pressure to
lower costs [3]. The Swiss Society of General Internal
Medicine (SSGIM), which represents general practi-
tioners (GPs) in Switzerland, launched the ‘Smarter
Medicine’ campaign (http://www.smartermedicine.ch)
in May 2014 with a list of five unnecessary tests and
treatments [4,5]. The five items address several facets
of ‘too much medicine’ in ambulatory general
internal medicine [6]: imaging for acute, uncompli-
cated low-back pain; prostate cancer screening with-
out discussing the risks and benefits; antibiotics for
uncomplicated upper respiratory tract infections;
preoperative chest radiography without clinical
suspicion of pathology; and long-term treatment with
proton pump inhibitors without titrating to the
lowest effective dose.
National experts (35) chose the items specifically
for the Swiss context, but the list’s impact on com-
munity based practice remains uncertain for several
reasons. First, the ‘Smarter Medicine’ campaign has
depended on effective diffusion of its message
through the traditional channels by which Swiss
physicians acquire new information. Extensive
research shows that recommendations alone do not
reliably change physician behaviour [7]. Second, while
physicians acknowledge that waste exists in our
healthcare system, they may be doubtful of their per-
sonal responsibility and what effect they can have on
costs [8]. Third, the data showing that the items in
the list are commonly overused, such as antibiotic
use in upper respiratory tract infections (URIs) and
imaging for low-back pain [9,10], come primarily from
Anglo-Saxon countries. The actual pattern of overuse
of Switzerland remains virtually unknown, except for
data showing regional variations and global indicators
such as antibiotic prescriptions per capita [11–13].
Finally, efforts to change practice will likely need to
be long-term and multifaceted, and must be guided
by an understanding of the underlying factors lead-
ing to prescribing ‘too much medicine’ [14].
Possibilities include a lack of updated knowledge,
physician routine, patient requests, inappropriate
incentives, or that physicians feel that guidelines are
not applicable for certain subgroups of patients [15].
The aims of this study were to assess general practi-
tioner (GP) awareness of the ‘Smarter Medicine’ cam-
paign, the relevance of the items to their daily
practice, reasons why they might not follow the rec-
ommendations, and their agreement with the recom-
mendations as published. We assessed these questions
among physicians participating in a practice-based
research network.
Methods
Setting and design
Both GPs and general internists provide primary care
in Switzerland, are represented by the SSGIM and are
referred to as GPs. Between 2012 and 2014, a SSGIM
committee identified low-value healthcare activities for
a Swiss top five list, as previously published [5]. After a
literature review, an online Delphi process was used
with 35 practicing GP-experts to rate existing recom-
mendations and offer new ones. The committee
members reported no conflicts of interests.
For the current study, we conducted an online sur-
vey with members of the Swiss primary care active
monitoring (SPAM) network, a national practice-based
research network. Results were collected between
August 2015 and May 2016, approximately two years
after the launch of the ‘Smarter Medicine’ top five list.
The SPAM network was created in 2012 with 200
members to monitor the practice patterns of Swiss
GPs [16]. To augment the membership and replace
physicians leaving the network, a further 3000 GPs
were invited to participate by mailed invitation in
2015, increasing the network to 277 members. These
277 members received a questionnaire that included a
section about ‘Smarter Medicine’ as part of the
SPAMPREV study. A Swiss Academy of Medical
Sciences funded the study about preventive medicine.
Approval for this study was obtained from the ethics
committee of the Canton of Vaud.
Survey instrument
The electronic survey instrument contained three sec-
tions. First, GPs were asked demographic questions
including the postal code of their practice (to deter-
mine if the practice was in a rural area) and in-practice
availability of a pharmacy, radiology, and laboratory
equipment.
Second, GPs were asked if they were aware of the
‘Smarter Medicine’ campaign, ‘Choosing Wisely’ and
the National Institute for Health and Clinical Excellence
(NICE) ‘do not do’ lists [1,17], based on a question
from a American Board of Internal Medicine (ABIM)
survey [18]. They were presented with each of the five
items from the ‘Smarter Medicine’ list and asked how
frequently they encountered the scenario presented in
their practice; how often, in that situation, they fol-
lowed the recommendation; reasons why they might
not follow the recommendation; and whether they
agreed with the recommendation as written in the
‘Smarter Medicine list.’ The physician practices ques-
tions were based on the ABIM survey and the
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methodology used by the National Physicians
Association to validate their top five lists [19]. The
physician agreement question used the same phrase
and 10-point Likert scale as used in for the original
‘Smarter Medicine’ list [5]. The survey was first devel-
oped and tested locally in French and is available
upon request. It was then translated into German and
Italian, and administered using online software from
SurveyMonkeyVR .
Statistical analysis
For each response, we calculated frequencies and
means as appropriate. A Poisson regression model was
built on the primary outcome of how many of the five
recommendations GPs reported not following more
often than ‘rarely or never’. Answering ‘rarely or never’
was considered following the recommendation, except
for discussing prostate cancer screening, where discus-
sing ‘most of the time’ before screening was consid-
ered following the recommendation. Provider
characteristics (sex, age, country of medical training,
experience in practice) and practice characteristics
(size, location and having an in-practice pharmacy,
laboratory and/or radiology equipment) were included
as independent variables as well as awareness of
‘Smarter Medicine’ and having mean acceptance of
greater than eight for the five recommendations.
Univariate analyses were first performed and variables
significant to a P-value less than 0.20 were retained for
multivariate modelling. Analyses were performed using
STATA version 14 (StataCorp).
Results
Of the 277 physicians participating in the SPAM net-
work, 167 completed the online survey (response rate
60%). Characteristics of the physicians participating are
shown in Table 1. As seen in Table 2, 62% of respond-
ents were aware of the Swiss ‘Smarter Medicine’ cam-
paign. Significantly, more respondents were aware of
‘Smarter Medicine’ in German-speaking areas (79%)
than in French and Italian-speaking areas (49 and 38%,
respectively).
The frequency with which GPs encounter the scen-
arios of the ‘Smarter Medicine’ top five list and the
proportion that report rarely going against the recom-
mendations are shown in Table 3. The proportion of
respondents saying that they rarely or never go
against each recommendation (or answered ‘most of
the time’ for the positively phrased question of discus-
sing prostate cancer screening before performing the
PSA) ranged from 34% for the recommendation to not
continue PPIs, or decrease the dose, to 74% for per-
forming preoperative chest X-rays. Physician agree-
ment with the recommendations on a 10-point Likert
scale (with 10 most likely to agree) is also shown in
Table 3. The agreement scores were high, around nine
out of 10.
The most frequent reasons for which physicians
might not follow each given recommendation are
shown in Table 4. The patient’s request was important
for imaging in low-back pain (67%) and providing anti-
biotics for URIs (73%), while the surgeon’s request was
important when performing preoperative chest X-rays
(68%). The number responding that this question was
not applicable to them as they always follow the rec-
ommendation ranged from 20% for not continuing
proton pump inhibitors, to 56% saying that they
always discuss prostate cancer screening prior to test-
ing. The responses that physicians lack time to follow
the recommendations are attempting to avoid a med-
ical error, are attempting to gain patient trust, or per-
form these tests for new or unknown patients were
rarely chosen (not shown).
Table 1. Characteristics of respondents from the
Swiss primary care active monitoring network
(n¼ 167).
Characteristic
Sex (women) 50 (30%)
Mean age (±SD) 54 (±8.9)
Language area
German 90 (54%)
French 61 (37%)
Italian 14 (8%)
Country of medical training (Switzerland) 151 (90%)
Years of experience in practice (±SD) 18 (±11)
Practice size
Solo practice 46 (28%)
2 to 4 physicians 105 (63%)
5 or more physicians 16 (10%)
Practice in rural area 43 (26%)
Average consultation <20min 70 (42%)
In practice:
Pharmacy 69 (41%)
Laboratory 143 (86%)
X-ray equipment 106 (63%)
Table 2. Awareness of campaigns to decrease overuse among
general practitioners (n¼ 167).
Question n (%)
Have you heard about the campaign ‘Smarter Medicine’
Yes 104 (62%)
No 45 (27%)
I don’t know 11 (7%)
Have you heard about the campaign ‘Choosing Wisely’
Yes 95 (57%)
No 63 (38%)
I don’t know 2 (1%)
Have you heard about the ‘do not do’ lists?
Yes 77 (46%)
No 73 (44%)
I don’t know 8 (5%)
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There were 159 GPs with complete responses to all
questions regarding whether the recommendations
are followed, of whom 2 (1%), 8 (5%), 27 (17%), 51
(32%), 49 (31%) and 22 (14%) reported following zero,
one, two, three, four and five recommendations
respectively. Multivariate Poisson regression found a
significant correlation between both average agree-
ment scores with the recommendations lower than
eight out of 10 and presence of an in-practice phar-
macy and following fewer recommendations (Table 5).
Discussion
Main findings
In this cross-sectional survey of practicing GPs from
throughout Switzerland, most physicians were aware of
the ‘Smarter Medicine’ campaign and agreed with its
recommendations. The only recommendation with less
than two-thirds reporting that they ‘rarely or never’ go
against the recommendation was to decrease the dose
or stop prescriptions for proton-pump inhibitors.
Table 3. Proportion of physicians who encounter clinical scenarios often or very oftena, who rarely or never go against each
‘Smarter Medicine’ recommendation, and mean agreement with recommendationb.
Clinical scenario Category Total (n¼ 167)
1. Patients with non-specific low-back pain Encountered often or very oftena 138 (83%)
Rarely or never get imaging 114 (68%)
Mean agreement with recommendation not to get imaging
for non-specific low-back pain (0–10)b
9.0 (±1.9)
2. Prostate cancer screening using prostate-
specific antigen test (PSA)
Encountered often or very oftena 97 (58%)
Discuss most of the time prior to screening 116 (69%)
Mean agreement with recommendation to discuss before
screening (0–10)b
8.9 (±1.7)
3. Upper respiratory tract infections without
signs of complications
Encountered often or very oftena 152 (91%)
Rarely or never prescribe antibiotics for these infections 113 (68%)
Mean agreement with recommendation not to prescribe anti-
biotics for these infections (0–10)b
9.1 (±1.5)
4. Patients without lung pathology for pre-
operative assessment
Encountered often or very oftena 79 (47%)
Rarely or never request a chest X-ray 124 (74%)
Mean agreement with recommendation not to request pre-
operative chest X-rays (0–10)b
9.2 (±1.4)
5. Long-term use of proton pump inhibitors
without confirmed pathology
Encountered often or very oftena 98 (59%)
Rarely or never continue medication without lowering dose 56 (34%)
Mean agreement with recommendation to not continue medi-
cation without lower dose (0–10)b
8.9 (±1.4)
aOften defined as weekly and very often as very often.
bOn a 10-point Likert scale, from 0 (complete disagreement) to 10 (complete agreement).
Table 4. Reasons why physicians go against the recommendations that received 12 or more positive responses, with several
responses possible (n¼ 167).
Recommendation Reasons for not following recommendation GPs responding yes (%)
1. Do not obtain imaging studies for patients
with non-specific low-back pain
Request or insistence of patient 89 (67%)a
Desired information from imaging 28 (21%)a
To increase bond with the patient 17 (13%)a
Not applicable as I always follow this recommendation 35 (21%)
2. Do not perform prostate cancer screening
without a discussion
PSA already ordered previously 45 (62%)a
Patients don’t want to discuss 15 (21%)a
I don’t have the time 12 (16%)a
Not applicable as I always follow this recommendation 94 (56%)
3. Do not prescribe antibiotics for uncompli-
cated respiratory tract infections
Prescribed for patients at high risk of complications 91 (73%)a
Request or insistence of patient 58 (46%)
For infections lasting more than 10 days 54 (43%)
Not applicable as I always follow this recommendation 42 (25%)
4. Do not obtain chest radiography in the
absence of suspected lung pathology
Requested by surgeon 78 (68%)a
Not applicable as I always follow this recommendation 53 (32%)
5. Do not continue long-term use of proton
pump inhibitors without titrating to the
lowest dose needed
PPIs continued to avoid recurrent symptoms 61 (46%)a
I allow patients to decide whether to continue medication 36 (27%)a
PPIs started by another physician 30 (22%)a
PPIs continued to avoid complications 18 (13%)a
Not applicable as I always follow this recommendation 33 (20%)
aThose responding ‘not applicable’ excluded from totals for percentages to other responses.
4 K. SELBY ET AL.
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ita
ire
 D
e L
au
sa
nn
e] 
at 
02
:33
 13
 Ja
nu
ary
 20
18
 
Reasons for not following the recommendations varied,
but patient request and desire for a test’s results were
more important drivers than lack of time or fear of
malpractice.
The wide recognition of the ‘Smarter Medicine’
campaign in our study was higher than similar studies
among community physicians [18,20] but lower than
among academic emergency medicine doctors [21].
It is likely that our sample of research network partici-
pants hear more often and earlier about trends in the
medical literature than their peers. With regards to the
difference between language areas, it is possible that
diffusion of ‘Smarter Medicine’ has been more effective
in German-speaking areas, or that the ‘Choosing
Wisely’ initiative in Germany, ‘Gemeinsam klug
entscheiden’, has raised awareness in Switzerland [22].
We focused on physician attitudes towards the top
five list and self-reported practices, one of three pos-
sible areas when assessing the impact of campaigns to
decrease use of low-value care [23]. If GPs agree with
the recommendations, they may be more likely to
follow them in practice, as there was a correlation
between giving agreement scores less than eight
and GPs reporting that they follow fewer
recommendations.
The association between having an in-practice phar-
macy and following more recommendations may be
primarily a marker for language area, as the over-
whelming majority of GPs with an in-practice phar-
macy are located in German-Switzerland. The only
medication-related recommendation was for discontin-
uing PPIs, and there was not a statistically significant
difference when examining responses of those with
and without a pharmacy.
Concerning following individual recommendations,
over two-thirds of GPs said that they rarely or never
go against the recommendation for each clinical
situation, except for lowering the dose or stopping
proton pump inhibitors (PPIs). There is extensive evi-
dence associating the chronic use of PPIs, especially at
high doses, with various adverse outcomes such as
increased infections, anaemia and fractures [24–26].
Despite multiple guidelines advocating for conserva-
tive, short-term use of PPIs in most situations, their
chronic use appears to be increasing rapidly [25,26].
PPIs have few immediate side effects and can reduce
dyspepsia, an extremely common and usually benign
symptom in the general population. These symptoms
often rebound after chronic PPIs are stopped. A simple
recommendation statement is likely to be inadequate
to decrease meaningfully the use of PPIs. Prior
research has shown that multiple interventions are
often necessary to influence practice [7].
When looking more broadly at reasons for not fol-
lowing the ‘Smarter Medicine’ recommendations, sev-
eral common themes emerge. Physicians often appear
to feel pressure to yield to the patient or other pro-
vider requests. Non-specific low back pain offers an
example where patients are often anxious and order-
ing imaging can be a tangible action that reassures
both physicians and patients and may strengthen the
therapeutic bond. Various hypotheses have been put
forward to explain why American physicians appear to
be deviating from guidelines for acute low-back pain
even more than previously, such as inappropriate
incentives and a plethora of different contradictory
information sources [27]. In our results, patient request
and GP desire for information were most frequently
cited, while inadequate time and avoiding a profes-
sional error were less important. These reasons are
similar to a Canadian family physicians survey where
patient request was the primary driver [23], but differ-
ent than an American survey where malpractice and
safety concerns were more important [18].
Table 5. Factors associated with following fewer of the ‘Smarter Medicine’ Top five recommendations (n¼ 159)a.
Characteristic
Univariate incidence rate
ratio (95%CI)b P
Multivariate incidence
rate ratio (95%CI)b P
Sex (women) 0.98 (0.77–1.25) 0.86 –
Age, years 1.00 (0.99–1.01) 0.91 –
Language area, German 0.75 (0.62–0.92) 0.01 1.05 (0.84–1.30) 0.69
Country of medical training, outside Switzerland 1.08 (0.73–1.61) 0.69 –
Experience in practice, years 1.00 (0.99–1.01) 0.90 –
Practice size, five or more physicians 0.82 (0.56–1.19) 0.30 –
Practice location, rural 1.01 (0.81–1.26) 0.91 –
In-practice pharmacy, yes 0.70 (0.57–0.86) <0.01 0.71 (0.57–0.88) 0.002
In-practice laboratory, yes 0.94 (0.66–1.35) 0.74 –
In-practice radiology, yes 0.93 (0.75–1.16) 0.53 –
Knows of ‘Smarter Medicine’ 0.91 (0.73–1.14) 0.42 – –
Mean agreement with recommendations 8c 1.62 (1.34–1.96) <0.01 1.60 (1.33–1.94) <0.001
aDefined as responding ‘nearly always’ for discussing prostate cancer screening prior to testing and ‘rarely or never’ to the other four clinical scenarios.
bIncidence rate ratio gives the ratio for following one additional recommendation.
cMean agreement for individual GPs with the five recommendation statements.
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Strengths and limitations
The generalizability of our results may be limited
because of selection bias on two levels. First, our
response rate of 60% and use of an electronic survey
may have a disproportionate number of GPs who are
better informed or more favourable of the ‘Smarter
Medicine’ campaign. Second, our participants were
GPs who had already agreed to be part of a practice-
based research network. However, the SPAM network
was designed to be representative and appears to be
reflective of practicing GPs based on demographic
characteristics [16]. In addition, longer-term data
should be collected to know whether this campaign
has a lasting impact.
Our results are based on physician report and not
actual practice, which could lead to overly optimistic
reporting from physicians due to social acceptability
bias. Future research could observe actual consulta-
tions or claims data. Early reports of the impact of the
‘Choosing Wisely’ campaign on physician prescribing
in other countries have been mixed [28,29]. However,
there is evidence that Switzerland has the lowest rates
of antibiotic prescription in Europe and low use of
imaging tests, suggesting that compliance may be
quite high at baseline. Finally, the cross-sectional,
observational nature of our results prevent us from
drawing conclusions about the cause of our findings,
and it remains unclear if interventions to increase GP
agreement with the recommendations would result in
more physicians following them. It is also unclear
whether the high rate of agreement with the recom-
mendations or adherence was temporally associated
with the ‘Smarter Medicine’ campaign.
Implications
These findings could have important implications as
the ‘Smarter Medicine’ campaign moves forward.
Given that awareness among GPs is already high, work
will be needed to sustain interest and there may be a
ceiling effect limiting the impact of future diffusion
efforts. The focus should be on ensuring physician
agreement, particularly for the limitation of PPI pre-
scription. Other interventions to promote top five lists
could help GPs redirect requests for low-value care,
extend the list beyond five items, and explore the clin-
ical scenarios in which GPs feel they need to go
against the recommendations.
Conclusion
Awareness of the ‘Smarter Medicine’ campaign, a
Swiss extension of the worldwide ‘Choosing Wisely’
movement, and agreement with its recommendations,
appear to be high among GPs. However, the recom-
mendation to decrease dosing or stop PPI’s is not
being followed consistently.
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